Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Gain-of-function suppressors restore microtubule dynamics and rescue dominant-negative tubulinopathies

AI Summary
  • Suppressor screens in Caenorhabditis elegans identify three distinct missense suppressor classes that counteract dominant-negative α and β tubulin mutants.
  • Intergenic suppressors restore microtubule architecture via two mechanisms: assembly-defective variants exclude mutant tubulins, assembly-competent variants modulate microtubule dynamics.
  • Effects are conserved in human cells and murine oocytes; TUBA1A gain-of-function suppressors restore protofilament geometry and outperform wild-type tubulin, suggesting therapeutic potential.
Summarise with AI (MRCPsych/FRANZCP)

Nat Cell Biol. 2026 Sep 11. doi: 10.1038/s41556-026-02066-9. Online ahead of print.

ABSTRACT

Missense mutations in tubulin-coding genes often exert dominant-negative effects on microtubule (MT) assembly, leading to developmental disorders collectively known as tubulinopathies. Here we performed suppressor screens in Caenorhabditis elegans and identified three functionally distinct classes of missense suppressors that counteract toxic α- and β-tubulin mutants. Intergenic suppressors-missense variants in the reciprocal tubulin gene-restore MT architecture via two distinct mechanisms: assembly-defective variants competitively exclude mutant tubulins, whereas assembly-competent variants modulate MT dynamics. These mechanisms are conserved and recapitulated in human cells and murine oocytes, where selected intergenic suppressors rescue pathogenic tubulin-induced MT defects and outperform wild-type tubulin supplementation. A systematic mutational analysis of TUBA1A further defines a landscape of gain-of-function assembly-competent suppressors, supported by molecular simulations showing restoration of protofilament geometry. Together, our results provide a structural and functional framework for tubulin suppression and highlight intergenic suppressors as potential candidates for precision therapeutics targeting dominant tubulinopathies.

PMID:42728306 | DOI:10.1038/s41556-026-02066-9

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD